The real-world data showed lower rates of atrial fibrillation and hypertension associated with the second-generation Bruton ...

While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...

A systematic review and subsequent expert review gave comprehensive insight into prognostic factors for patients receiving ...

The meta-analysis of 9 studies showed high sensitivity with slightly lower specificity with the less-invasive option for ...

Pieter Sonneveld, MD, PhD, professor of hematology and chair of the Erasmus MC Cancer Institute in Rotterdam, Netherlands, ...

Meaningful transformation in health care requires ongoing, collaborative efforts, explained Eboni Price-Haywood, MD, MPH, MMM, Xavier Ochsner College of Medicine; and Toni Flowers, PhD, DHL, MBA, LCMC ...

Novel therapies for multiple myeloma (MM), including chimeric antigen receptor T-cell and bispecific antibodies, extend lives but raise concerns about treatment costs and adherence, and they haven't ...

Employers discover innovative strategies for enhancing employee engagement and access to care at the Greater Philadelphia Business Coalition on Health (GPBCH) Annual Conference, fostering actionable ...

The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

Despite advances in diabetes care, new research reveals persistent economic disadvantages for middle-aged adults living with ...